ArticleJournal of microbiology and biotechnology2026
Targeting the ROS-JNK/p38 Axis: Schisandrin A as a Novel Therapeutic Candidate for Esophageal Squamous Cell Carcinoma.
Minjun Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.